Unknown Diabetes, Hormones & Metabolism NIHR-supported project Cancer
A randomised, adaptive, open label, parallel group, multicentre platform trial in adults with newly diagnosed type 1 diabetes (t1d-plus)
About this grant
This summary is based on the grant title only — the full abstract was not available.
No substantive source abstract was published for this research project funded by NIHR.
Researchers
Mark Evans (Principal Investigator)
Related Research
Grants with similar aims, by meaning.
T1D-PLUS - An adaptive platform trial by INNODIA - A RANDOMISED, ADAPTIVE, OPEN LABEL, PARALLEL GROUP, MULTICENTRE PLATFORM TRIAL IN ADULTSWITH NEWLY DIAGNOSED TYPE 1 DIABETES
T1D Plus
Peri-operative closed-loop insulin delivery versus standard insulin therapy- a randomised controlled parallel clinical trial in adults with type 2 diabetes (POP-LOOP)
Supporting people with type 2 diabetes in effective use of their medicine through a system comprising mobile health technology integrated with clinical care compared with usual care: a randomised feasibility trial.
Supporting people with type 2 diabetes in effective use of their medicine through a system comprising mobile health technology integrated with clinical care compared with usual care: a randomised controlled trial
Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research. Is something wrong? Let us know